NCK2 |
NCK2: Cytoplasmic protein NCK2 |
CSK |
CSK: Tyrosine-protein kinase CSK |
408.000 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
CRKL |
CRKL: Crk-like protein |
408.000 |
Evidence |
|
HCK |
IPI00029769 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
407.000 |
Evidence |
|
CRKL |
CRKL: Crk-like protein |
JAK1 |
|
407.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
407.000 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
407.000 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
LYN |
LYN: Tyrosine-protein kinase Lyn |
407.000 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
407.000 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
JAK1 |
|
407.000 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CRKL |
CRKL: Crk-like protein |
407.000 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
CRKL |
CRKL: Crk-like protein |
407.000 |
Evidence |
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
CHTF18 |
RUVBL, CHTF18: Protein CTF18 homolog. |
406.000 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
CFL1 |
CFL1, CFL: Cofilin-1 |
403.000 |
Evidence |
|
PRKAA2 |
PRKAA2, AMPK, AMPK2: 5'-AMP-activated protein kinase catalytic subunit alpha-2 |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
403.000 |
Evidence |
|
EIF4E |
EIF4E, EIF4EL1, EIF4F: Eukaryotic translation initiation factor 4E |
PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
402.000 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
401.000 |
Evidence |
|
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
400.000 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
C6 |
C6: Complement component C6 precursor |
393.000 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
392.000 |
Evidence |
|
C1R |
C1R: Complement C1r subcomponent precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
392.000 |
Evidence |
|
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
LYN |
LYN: Tyrosine-protein kinase Lyn |
392.000 |
Evidence |
|
HCK |
IPI00029769 |
SYK |
SYK: Tyrosine-protein kinase SYK |
392.000 |
Evidence |
|
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
392.000 |
Evidence |
|
HCK |
IPI00029769 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
392.000 |
Evidence |
O
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
392.000 |
Evidence |
|